Division of Pediatric Hematology/Oncology

Clinical Trials

Rhabdomyosarcoma

• ARST0331: Phase III— Vincristine, Dactinomycin, and lower doses of Cyclophosphamide with or without radiation therapy for patients with newly diagnosed, low-risk embryonal/botryoid /spindle cell rhabdomyosarcoma
  Principal investigator: Cindy Schwartz, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back